10 Pulmonary Hypertension Clinical Trials in Hollywood, CA (2026)

Q: How do I join a clinical trial in Hollywood?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Hollywood research site will contact you.

Recruiting Pulmonary Hypertension Studies in Hollywood

NCT07412002Recruiting

Quality of End-of-Life Care for Children With Cancer

This study examines the role of access to care, patient/family interactions with the healthcare system, and stress in explaining variations in quality of end of life care. The data collected from this...

Hollywood, CA2,425 participantsChildren's Oncology Group

View Study Details

NCT05184335Recruiting

Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia

This study is to evaluate the effect and safety of Brilaroxazine in patients with acute schizophrenia compared to the placebo short and long-term. Brilaroxazine will be given at fixed doses of 15 mg o...

Hollywood, CA690 participantsReviva Pharmaceuticals

View Study Details

NCT06935357Recruiting

A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN)

In this study, researchers will learn more about the use of felzartamab in participants with immunoglobulin A nephropathy (IgAN). This study will focus on participants who have protein in their urine ...

Hollywood, CA454 participantsBiogen

View Study Details

NCT06963034Recruiting

NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia

The primary objective for this study is to evaluate the efficacy of NBI-1117568 compared with placebo on improving behavioral and psychological symptoms of schizophrenia in adults....

Hollywood, CA284 participantsNeurocrine Biosciences

View Study Details

NCT05268289Recruiting

Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V

The overall purpose of this two-part study is to evaluate the efficacy, safety and tolerability of iptacopan (LNP023) in addition to standard of care treatment....

Hollywood, CA240 participantsNovartis Pharmaceuticals

View Study Details

NCT07191483Recruiting

A Study to Evaluate KYN-5356 in Adults With Cognitive Impairment Associated With Schizophrenia

This is a Phase 2, randomized, double-blind, placebo-controlled study to evaluate the efficacy, safety, Pharmacokinetic (PK) and Pharmacodynamic (PD) effects of 3 different dose regiments of KYN-5356 ...

Hollywood, CA150 participantsKynexis B.V.

View Study Details

NCT07061288Recruiting

A Study to Evaluate the Safety, Tolerability, and PK of an Injectable Form of KarXT

A study to evaluate the safety, tolerability, and PK of an injectable form of KarXT in participants with schizophrenia...

Hollywood, CA116 participantsBristol-Myers Squibb

View Study Details

NCT04920617Recruiting

DPX-Survivac and Pembrolizumab With and Without Intermittent Low-Dose Cyclophosphamide, in Subjects With Relapsed/Refractory Diffuse Large B-Cell Lymphoma

This is a Phase 2b, randomized, open label study to assess the safety and efficacy of DPX-Survivac and pembrolizumab, with and without low-dose cyclophosphamide (CPA) in subjects with relapsed or refr...

Hollywood, CA102 participantsImmunoVaccine Technologies, Inc. (IMV Inc.)

View Study Details

NCT06502964Recruiting

Study of ALTO-101 in Patients With Schizophrenia

This is a Phase 2, double-blind, placebo-controlled, two-way crossover study to compare the efficacy of ALTO-101T versus placebo in change in electroencephalogram (EEG) cognitive processing markers an...

Hollywood, CA82 participantsAlto Neuroscience

View Study Details

NCT05886036Recruiting

Comparing the Effectiveness of the Immunotherapy Agents Rituximab or Mosunetuzumab in Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma, NORM Trial

This phase II trial compares mosunetuzumab to the usual treatment (rituximab) for improving survival in patients with nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL). Rituximab and mosunetuzum...

Hollywood, CA70 participantsNational Cancer Institute (NCI)

View Study Details

About Pulmonary Hypertension Clinical Trials in Hollywood

Pulmonary hypertension is a type of high blood pressure that affects the arteries in the lungs and the right side of the heart. It can lead to heart failure if untreated. Treatment includes vasodilators, endothelin receptor antagonists, and PDE-5 inhibitors.

There are currently 10 pulmonary hypertension clinical trials recruiting participants in Hollywood, CA. These studies are seeking a combined 4,613 participants. Research is being sponsored by Children's Oncology Group, Reviva Pharmaceuticals, Biogen and 7 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Pulmonary Hypertension Clinical Trials in Hollywood — FAQ

Are there pulmonary hypertension clinical trials in Hollywood?

Yes, there are 10 pulmonary hypertension clinical trials currently recruiting in Hollywood, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Hollywood?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Hollywood research site will contact you about next steps.

Are clinical trials in Hollywood free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Hollywood studies also compensate for your time and travel.

What pulmonary hypertension treatments are being tested?

The 10 active trials in Hollywood are testing new therapies including novel drugs, biologics, and treatment approaches for pulmonary hypertension.

Data updated July 13, 2026 from ClinicalTrials.gov